UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net (loss) income	$ 1,163	$ (2,075)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation	7,824	6,211
Amortization of intangibles	4,004	2,196
Amortization of deferred financing costs	775	1,272
Change in deferred income tax	198	1,197
Compensation under stock-based compensation plans	3,982	2,726
Loss on disposal of fixed assets	157	125
Changes in assets and liabilities, net of acquired business:
Receivables, net of bad debt expense	(19,127)	1,972
Inventory	28,545	(10,834)
Prepaid expenses and other assets	4,270	(6,618)
Accounts payable	(5,592)	7,100
Claims payable	487	530
Amounts due to plan sponsors	3,162	3,051
Accrued interest	5,803	13,194
Accrued expenses and other liabilities	3,892	(14,157)
Net cash provided by operating activities	39,543	5,890
Cash flows from investing activities:
Purchases of property and equipment, net	(6,499)	(6,747)
Cash consideration paid to CHS, net of cash acquired	0	(92,464)
Cash consideration paid to DS Pharmacy	0	(4,969)
Cash consideration paid for asset acquisitions	(463)	0
Net cash used in investing activities	(6,962)	(104,180)
Cash flows from financing activities:
Cash consideration paid for Option Health earn-out	0	(1,000)
Proceeds from new credit facility, net of fees paid to issuers	0	319,000
Borrowings on line of credit	1,294,569	300,310
Repayments on line of credit	(1,325,882)	(330,699)
Repayments of capital leases	(2,568)	(72)
Principal payments on CHS long-term debt, paid at closing	0	(128,952)
Principal payments on long-term debt	0	(1,250)
Repayment of note payable	0	(2,250)
Deferred and other financing costs	(22)	(8,680)
Net proceeds from exercise of employee stock compensation plans	1,460	2,990
Surrender of stock to satisfy minimum tax withholding	(138)	(128)
Net cash (used in) provided by financing activities	(32,581)	149,269
Net change in cash and cash equivalents	0	50,979
Cash and cash equivalents - end of period	0	0
Cash and cash equivalents - end of period	0	50,979
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	15,031	5,038
Cash paid during the period for income taxes, net of refunds	(3,175)	1,803
Capital lease obligations incurred to acquire property and equipment	$ 5,930	$ 0